Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$1.01 - $17.0 $12,928 - $217,600
12,800 New
12,800 $19,000
Q2 2021

Aug 11, 2021

SELL
$6.81 - $9.23 $219,963 - $298,129
-32,300 Reduced 50.0%
32,300 $260,000
Q1 2021

May 17, 2021

BUY
$7.99 - $15.0 $138,227 - $259,500
17,300 Added 36.58%
64,600 $537,000
Q3 2020

Nov 16, 2020

BUY
$9.98 - $18.04 $2,994 - $5,412
300 Added 0.64%
47,300 $504,000
Q2 2020

Aug 14, 2020

SELL
$7.49 - $15.16 $558,005 - $1.13 Million
-74,500 Reduced 61.32%
47,000 $713,000
Q1 2020

May 15, 2020

SELL
$4.62 - $18.74 $36,960 - $149,920
-8,000 Reduced 6.18%
121,500 $1.01 Million
Q4 2019

Feb 14, 2020

SELL
$14.6 - $18.13 $211,700 - $262,885
-14,500 Reduced 10.07%
129,500 $2.19 Million
Q3 2019

Nov 14, 2019

BUY
$16.62 - $23.92 $81,438 - $117,208
4,900 Added 3.52%
144,000 $2.67 Million
Q2 2019

Aug 14, 2019

SELL
$17.79 - $22.88 $6.45 Million - $8.29 Million
-362,400 Reduced 72.26%
139,100 $3.18 Million
Q1 2019

May 15, 2019

BUY
$11.76 - $22.15 $2.43 Million - $4.58 Million
206,800 Added 70.17%
501,500 $10.5 Million
Q4 2018

Feb 14, 2019

BUY
$10.42 - $21.94 $1.81 Million - $3.81 Million
173,700 Added 143.55%
294,700 $3.39 Million
Q3 2018

Nov 14, 2018

SELL
$20.4 - $24.6 $102,000 - $123,000
-5,000 Reduced 3.97%
121,000 $2.78 Million
Q2 2018

Aug 14, 2018

SELL
$19.02 - $24.95 $138,846 - $182,135
-7,300 Reduced 5.48%
126,000 $2.81 Million
Q1 2018

May 15, 2018

SELL
$22.55 - $29.9 $2.42 Million - $3.2 Million
-107,100 Reduced 44.55%
133,300 $3.05 Million
Q4 2017

Feb 14, 2018

BUY
$18.0 - $30.0 $2.36 Million - $3.93 Million
131,100 Added 119.95%
240,400 $6.3 Million
Q3 2017

Nov 14, 2017

BUY
$21.1 - $25.15 $2.31 Million - $2.75 Million
109,300
109,300 $2.45 Million

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.